Biohaven Pharma (BHVN) Misses Q4 EPS by 11c
Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($1.71), $0.11 worse than the analyst estimate of ($1.60).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($1.71), $0.11 worse than the analyst estimate of ($1.60).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.